Arcalyst (rilonacept) 220MG/vial injection
Ended Awarded Last action
- Contract number
- 36C26022F0186
- Awardee
-
Kiniksa Pharmaceuticals (Uk), LTD. UEI HBHWNLNMHSV5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $30,010
Award facts
- Contract value 100% obligated
- $30,009.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$11,990 | |
| Funding Only Action | -$21,000 | |
| Original award | $63,000 |
About this award
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Kiniksa Pharmaceuticals (UK), LTD, the prime contractor. The contract is for the procurement of ARCALYST (RILONACEPT) 220MG/VIAL INJECTION, a drug used to treat chronic inflammatory disorders. The contract has a potential value of $30,009.68 and a completion date of April 30, 2022. This contract is issued against Kiniksa's Pharmaceuticals and Drugs GSA Schedule contract, and Kiniksa will provide the medication from its facility in Great Britain to support healthcare programs for veterans. No set-aside designation is mentioned. Kiniksa also holds two larger indefinite-delivery vehicles against the Pharmaceuticals and Drugs Federal Supply Schedule, including a $5.9 million single award blanket purchase agreement with the VA National Acquisition Center through November 2024 and a $700,000 multiple award schedule contract with VHA through October 2026, both focused on delivering Arcalyst (Rilonacept) to VA locations.
Quick answers
Who was awarded contract 36C26022F0186?
36C26022F0186 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 2, 2022.
How much is contract 36C26022F0186 worth?
The government has obligated $30,010 on 36C26022F0186.
Is contract 36C26022F0186 an order under another contract?
Yes. 36C26022F0186 is a delivery order under 36F79722D0002, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26022F0186 competed?
The extent of competition for 36C26022F0186 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award